Cargando…
Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?
In recent years, it has come a long way in the diagnosis, treatment, and follow-up of prostate cancer. Beside this, it was argued that definitive treatments could cause overtreatment, particularly in the very low, low, and favorable risk group. When alternative treatment and follow-up methods are be...
Autores principales: | Demirel, Cihan H, Altok, Muammer, Davis, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337958/ https://www.ncbi.nlm.nih.gov/pubmed/30178774 http://dx.doi.org/10.4103/aja.aja_64_18 |
Ejemplares similares
-
Impact of MRI/US fusion‐guided prostate biopsy on biopsy‐naïve patients: A single urologist’s experience
por: Altok, Muammer, et al.
Publicado: (2021) -
Management of localized prostate cancer: the pendulum swings (back to the middle)
por: Vuong, Winston, et al.
Publicado: (2014) -
Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates
por: Altok, Muammer, et al.
Publicado: (2019) -
Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy
por: Chapin, Brian F
Publicado: (2015) -
Active surveillance for prostate cancer: when to recommend delayed intervention
por: Babaian, Kara N
Publicado: (2015)